Free Trial

TransMedics Group (TMDX) Insider Trading & Ownership

TransMedics Group logo
$72.92 -22.01 (-23.19%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$73.45 +0.53 (+0.73%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group (NASDAQ:TMDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$5.66M
Get TMDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling TransMedics Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMDX Insider Buying and Selling by Quarter

TransMedics Group Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2026
David Weill
David Weill
Director
Sell3,571$146.82$524,294.22  
3/4/2026Sell7,236$147.21$1,065,211.56  
3/4/2026
Stephanie Lovell
Director
Sell1,193$149.62$178,496.66  
3/2/2026Sell864$139.12$120,199.68  
3/2/2026Sell375$139.12$52,170.00  
3/2/2026Sell2,966$139.12$412,629.92  
12/4/2025Sell920$139.62$128,450.40  
12/3/2025
David Weill
David Weill
Director
Sell5,000$138.64$693,200.00  
11/25/2025Sell3,000$145.22$435,660.00  
10/29/2025
Edward M Basile
Director
Sell4,142$130.45$540,323.90  
6/9/2025Sell686$139.80$95,902.80  
5/27/2025
Edward M Basile
Director
Sell5,000$126.45$632,250.00  
5/23/2025
David Weill
David Weill
Director
Sell732$123.88$90,680.16  
5/9/2025
Edward M Basile
Director
Sell6,000$115.63$693,780.00  
(Data available from 1/1/2013 forward)

TMDX Insider Trading Activity - Frequently Asked Questions

The list of insiders at TransMedics Group includes Anil P Ranganath, David Weill, Edward M Basile, Gerardo Hernandez, James R Tobin, Miriam Provost, Nicholas Corcoran, Stephanie Lovell, Stephen Gordon, Tamer I Khayal, and Waleed H Hassanein. Learn more on insiders at TMDX.

6.90% of TransMedics Group stock is owned by insiders. Learn more on TMDX's insider holdings.

The following insiders have sold TMDX shares in the last 24 months: Anil P Ranganath ($1,399,600.91), David Weill ($1,801,712.83), Edward M Basile ($4,372,813.26), Gerardo Hernandez ($1,245,831.96), James R Tobin ($3,186,600.00), Nicholas Corcoran ($2,172,829.92), Stephanie Lovell ($178,496.66), Stephen Gordon ($3,108,015.80), Tamer I Khayal ($1,389,853.18), and Waleed H Hassanein ($4,943,418.75).

Insiders have sold a total of 167,547 TransMedics Group shares in the last 24 months for a total of $23,799,173.27 sold.



This page (NASDAQ:TMDX) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners